Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acmella oleracea extract, derived from the jambu or toothache plant, is a botanical medicinal and cosmetic ingredient characterized by its high concentration of N-alkylamides, specifically spilanthol. It exhibits potent local anesthetic, analgesic, anti-inflammatory, and myorelaxant properties. In the dental field, it is used to treat dentin hypersensitivity, aphthous stomatitis, and pain associated with tooth bleaching. In dermatology and cosmetics, it is frequently marketed as a "natural Botox" alternative due to its ability to induce muscle relaxation, which reduces the appearance of facial expression lines and wrinkles. Mechanistically, it acts as a partial agonist of the TRPV1 receptor and an agonist of the CB2 receptor, and it also demonstrates neuro-relaxing activity by modulating acetylcholine-mediated pathways at the neuromuscular junction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acmella oleracea extract.